In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | |
| Other Income | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Income | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | |
| Expenses | |||||||||||||
| + Employee Benefit Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Other Expenses | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.1 | 0.1 | 0.2 | |
| Total Expenses | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.2 | |
| EBITDA | -0.0 | -0.0 | -0.0 | -0.1 | -0.0 | -0.0 | -0.1 | -0.1 | -0.2 | -0.1 | 0.1 | -0.2 | |
| EBIT | -0.0 | -0.0 | -0.0 | -0.1 | -0.0 | -0.0 | -0.1 | -0.1 | -0.2 | -0.1 | 0.1 | -0.2 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | -0.0 | 0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.1 | -0.2 | -0.1 | 0.1 | -0.2 | |
| + Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Pretax Income | -0.0 | 0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -2.5 | -0.1 | -0.2 | -0.1 | 0.1 | -0.2 | |
| + Share of Associates & JVs | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net Income | -0.0 | 0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -2.5 | -0.1 | -0.2 | -0.1 | 0.1 | -0.2 | |
| + Net Income — Continuing Ops | -0.0 | 0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -2.5 | -0.1 | -0.2 | -0.1 | 0.1 | -0.2 | |
| + Other Comprehensive Income | 0.1 | 0.0 | -0.0 | 0.3 | 0.1 | -0.0 | -0.5 | 0.3 | -0.0 | -0.0 | -0.0 | 0.0 | |
| Total Comprehensive Income | 0.1 | 0.1 | -0.0 | 0.2 | 0.1 | -0.0 | -3.0 | 0.2 | -0.2 | -0.1 | 0.1 | -0.2 | |
| Per Share | |||||||||||||
| Basic EPS | 0.01 | 0.01 | 0.00 | -0.01 | 0.00 | 0.00 | -0.46 | -0.02 | -0.03 | -0.02 | 0.02 | -0.04 | |
| Diluted EPS | 0.01 | 0.01 | 0.00 | -0.01 | 0.00 | 0.00 | -0.46 | -0.02 | -0.03 | -0.02 | 0.02 | -0.04 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Other Comprehensive Income | — | — | — | — | — | — | -0.5 | 0.3 | -0.0 | -0.0 | -0.0 | — | |
| + Tax on Items NOT to be Reclassified | — | — | — | — | — | — | 0.5 | -0.3 | 0.0 | 0.0 | 0.0 | — | |
| + Tax on Items NOT to be Reclassified — alt tag | — | -0.0 | 0.0 | -0.3 | -0.1 | 0.0 | — | — | — | — | — | — | |
| + Net Movement — Regulatory Deferral Balances | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | 0.01 | 0.01 | 0.00 | -0.01 | 0.00 | 0.00 | -0.46 | -0.02 | -0.03 | -0.02 | 0.02 | -0.04 | |
| Diluted EPS — Continuing Operations | 0.01 | 0.01 | 0.00 | -0.01 | 0.00 | 0.00 | -0.46 | -0.02 | -0.03 | -0.02 | 0.02 | -0.04 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||||||||
| Related-party Transactions — During the Period | — | — | — | — | — | — | 1.0 | — | 2.6 | — | 3.7 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||||||||
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | |
| Gross Margin % | 100.00 | 100.00 | 100.00 | — | — | — | — | — | — | — | 100.00 | — | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | -0.0 | 0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.1 | -0.2 | -0.1 | 0.1 | -0.2 | |
| − Exceptional Items (reconciliation) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net Income Adj (tax-effected) | -0.0 | 0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.1 | -0.2 | -0.1 | 0.1 | -0.2 | |
| EPS Adj | 0.01 | 0.01 | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 | -0.02 | -0.03 | -0.02 | 0.02 | -0.04 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | |
| Paid Up Equity Capital | 11.1 | 11.1 | 11.1 | 11.1 | 11.1 | 11.1 | 11.1 | 11.1 | 11.1 | 11.1 | 11.1 | 11.1 | |